NCT05825911 Evaluation of Diagnostic Accuracy of MCG(Magnetocardiography) Scan in Suspected Coronary Artery Disease
| NCT ID | NCT05825911 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AMCG |
| Condition | Coronary Artery Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 908 participants |
| Start Date | 2024-06-24 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 908 participants in total. It began in 2024-06-24 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This multicenter clinical trial is designed to evaluate the diagnostic accuracy of MCG scan in detecting significant CAD compared to the reference standard CAG.
Eligibility Criteria
Inclusion Criteria: * Over 19 years of age at the time of enrollment * Patient presenting for CAG * Consents to having an MCG scan study Exclusion Criteria: * Patients unable to fit into MCG scan device * Patients with implanted cardiac pacemakers/defibrillators * Atrial fibrillation with rapid ventricular response * Patients with other sustained or incessant arrhythmias * Presence clinical suspicious of any acute coronary syndrome
Contact & Investigator
Hoseong Lee Deputy general manager
STUDY DIRECTOR
AMCG
Frequently Asked Questions
Who can join the NCT05825911 clinical trial?
This trial is open to participants of all sexes, aged 19 Years or older, up to 80 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05825911 currently recruiting?
Yes, NCT05825911 is actively recruiting participants. Contact the research team at lhs@amcg.kr for enrollment information.
Where is the NCT05825911 trial being conducted?
This trial is being conducted at Seoul, South Korea, Incheon, South Korea.
Who is sponsoring the NCT05825911 clinical trial?
NCT05825911 is sponsored by AMCG. The principal investigator is Hoseong Lee Deputy general manager at AMCG. The trial plans to enroll 908 participants.